Scientific Programme



SIENTIFIC PROGRAMME (PDF)



Thursday, March 14th, 2024
13:00 – 17:00 REG Working Group Research Ideas Brainstorming
Friday, March 15th, 2024
08:50 – 09:00 Welcome
Prof. G. Walter Canonica
09:00 – 09:55 Vaccines Session
Chair: Dr. Dermot Ryan

Epidemiologic perspective of vaccination in respiratory diseases
Dr. Joan Soriano

Vaccinations & the respiratory patient –  Recommendations vs real world use
Dr. Alan Kaplan
09:55 – 10:30 ILD/IPF Session
Chair: Dr. Pilar Rivera Ortega

Update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: A look towards 2023 and beyond
Prof. Luca Richeldi

Q & A
10:30 – 11:00 Coffee Break
11:00 – 12:30 Asthma Session
Chair: Prof. Arnaud Bourdin

Mild asthma, update on anti-inflammatory reliever
Prof. Alberto Papi

When to institute triple therapy – Should all patients go through triple therapy and azithromycin before biologics?
Prof. Michael Wechsler
12:30 – 13:30 Lunch Break
13:30 – 14:30 COPD Session
Chair: Prof. Therese Lapperre

New definitions of exacerbation of COPD: Are they ready for clinical practice?
Prof. Marc Miravitlles 

What's next after triple therapy in COPD?
Prof. David Halpin

Q & A
14:30 – 15:15 Rhinitis Session
Chair: Dr. Ignacio Ansotegui

Novel therapies in rhinitis
Dr. Ignacio Ansotegui

 Rhinitis & asthma – what does the RWE tell us?
Prof. Philippe Gevaert

 AIT & Biologics: a new opportunity of combination treatment
Prof. G. Walter Canonica

 Q & A
15:15 – 15:45 Coffee Break

In the Respiratory hot seat:
15:45 – 16:30 PRO/CON Remission in severe asthma is attainable in most patients
Chair: Prof. Celeste Porsbjerg

PRO: Prof. Michael Wechsler
CON: Dr. Alan Kaplan
16:30 – 17:15 PRO/CON DPIs are the devices of choice in COPD or asthma
Chair: Prof. Job Van Boven

PRO: Prof. Federico Lavorini
CON: Jane Scullion
Saturday, March 16th, 2024
09:00 – 09:45 Cough session
Chair: Dr. Alan Kaplan

Specific cough-targeting drugs: past, present, and future
Prof. Surinder Birring

 Q & A
09:45 – 10:30 Mild – Moderate disease management session
Chair: Prof. Nikos Papadopoulos 

Identifying which patients progress to severe asthma – new evidence from MANI registry
Prof. Fulvio Braido

Disease modifying drugs in asthma
Prof. Christian Virchow
10:30 – 11:00 Coffee Break
11:00 – 12:15 ISAR SESSION
Improving the patient journey in severe asthma- lessons from ISAR and future research

Chair: Prof. David Price & Dr. Eileen Wang

Why is quality improvement needed (patient and specialist perspectives)
Prof. Celeste Porsbjerg

What has ISAR achieved to date in improving severe asthma care globally (standardized data collection)
Prof. Chin Kook Rhee

What remains to be achieved by ISAR (practice change goals based on prior research)
Dr. Celine Bergeron

What are the future research needs for ISAR as a network?
Prof. Matthew Peters
12:15 – 13:00 Keynote
What Registries have taught us in the last decade.
Chair: Prof. Sinthia Bosnic – Anticevich

Panel:
Prof. David Price
Prof. Nicolas Roche 
Prof. Fulvio Braido
Prof. Chin Kook Rhee
13:00 Meeting Close